Immune Design Corp.
IMDZ
IMDZ was delisted on the 1st of April, 2019.
59 hedge funds and large institutions have $130M invested in Immune Design Corp. in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 11 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 15
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less funds holding
Funds holding: 67 → 59 (-8)
38% less capital invested
Capital invested by funds: $209M → $130M (-$79.5M)
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
+$934K |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$610K |
| 3 |
NC
Nexthera Capital
New York
|
+$521K |
| 4 |
State Street
Boston,
Massachusetts
|
+$497K |
| 5 |
SIM
Spark Investment Management
New York
|
+$426K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.58M |
| 2 |
TA
Teachers Advisors
New York
|
-$1.37M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.35M |
| 4 |
Jennison Associates
New York
|
-$409K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$275K |
IMDZ Hedge Fund Activity: Q1 2016 in Review
59 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q1 2016, worth a combined $130M — down 38% from $209M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of IMDZ and 3 opened new positions — a net loss of 8 holders — while 15 trimmed existing stakes and 25 added.
The largest buyer was RS Investment Management, adding an estimated $934K. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $6.58M sold.
- 59 institutional investors held Immune Design Corp. (IMDZ) as of Q1 2016, down from 67 in Q4 2015.
- Funds reported $130M of Immune Design Corp. stock for Q1 2016, down 38% quarter-over-quarter.
- 3 funds opened new Immune Design Corp. positions in Q1 2016 and 11 closed out, a net change of -8 holders.
- The largest Immune Design Corp. buyer in Q1 2016 was RS Investment Management, an estimated $934K added.
- The largest Immune Design Corp. seller in Q1 2016 was T. Rowe Price Associates, an estimated $6.58M sold.
Based on aggregated 13F filings for Q1 2016.